PAULSON & CO. INC. 13D and 13G filings for Madrigal Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 4:43 pm Sale | 2026-03-31 | 13G | MADRIGAL PHARMACEUTICALS INC C MDGL | PAULSON & CO. INC. | 1,392,188 6.100% | -315,334 (-18.47%) | Filing |
| 2026-02-17 5:19 pm Sale | 2025-12-31 | 13G | MADRIGAL PHARMACEUTICALS INC C MDGL | PAULSON & CO. INC. | 1,707,522 7.500% | -334,478 (-16.38%) | Filing |
| 2024-11-14 5:18 pm Purchase | 2024-09-30 | 13G | MADRIGAL PHARMACEUTICALS INC C MDGL | PAULSON & CO. INC. | 2,042,000 9.400% | 936,259 (+84.67%) | Filing |
| 2024-02-14 4:47 pm Purchase | 2023-12-31 | 13G | MADRIGAL PHARMACEUTICALS INC C MDGL | PAULSON & CO. INC. | 1,105,741 5.600% | 105,741 (+10.57%) | Filing |
| 2023-11-13 4:39 pm Purchase | 2023-11-01 | 13G | MADRIGAL PHARMACEUTICALS INC C MDGL | PAULSON & CO. INC. | 1,000,000 5.100% | 1,000,000 (New Position) | Filing |